Transaction · 0001104659-26-105509

Teyssedou Lenaic Nathanael

Teyssedou Lenaic Nathanael, PAO, reported a transaction classified as grant at Addex Therapeutics Ltd. involving 37770.000000 shares for an estimated $0.00. Reported holdings after the transaction were 602908.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code APAO
ADXNAddex Therapeutics Ltd.
Trade date
Sep 02, 2026
Filing date
Sep 04, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded37.7k$0.00 per share
Holdings after602kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ADXN price since this filing

Daily closing prices, with the filing date and available return windows
ADXN · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d -4.4%30d -15.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001104659-26-105509
Stock-option (Right to Buy)
Transaction date
Sep 02, 2026
Filed Sep 04, 2026, 08:11 PM · 2d delay
Shares
37,770 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
602,908 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRINCIPAL ACCOUNTING OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    On September 2, 2026, following the implementation of the Remuneration Committee's decision, the exercise price of the options were repriced to $0.032. All of the other terms of the options remain unc…

  2. F2

    The exercise price is reported in U.S. dollars and reflects the conversion from CHF to USD at an exchange rate of $1.2296 per CHF 1.00 as of September 2, 2026.

Original filing · 0001104659-26-105509
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ADXN